Author:
Lista Simone,Vergallo Andrea,Teipel Stefan J.,Lemercier Pablo,Giorgi Filippo Sean,Gabelle Audrey,Garaci Francesco,Mercuri Nicola B.,Babiloni Claudio,Gaire Bhakta Prasad,Koronyo Yosef,Koronyo-Hamaoui Maya,Hampel Harald,Nisticò Robert
Subject
Neurology,Molecular Biology,Aging,Biochemistry,Biotechnology
Reference316 articles.
1. Role of cholinesterase inhibitors in Parkinson’s disease and dementia with Lewy bodies;Aarsland;J. Geriatr. Psychiatry Neurol.,2004
2. Short-term rivastigmine treatment reduces EEG slow-wave power in Alzheimer patients;Adler;Neuropsychobiology,2001
3. Prediction of treatment response to rivastigmine in Alzheimer’s dementia;Adler;J. Neurol. Neurosurg. Psychiatry,2004
4. Developing retinal biomarkers for the earliest stages of Alzheimer’s disease: What we know, what we don’t, and how to move forward;Alber;Alzheimers Dement,2020
5. Albin, R.L., van der Zee, S., van Laar, T., Sarter, M., Lustig, C., Muller, M.L.T.M., Bohnen, N.I., 2022, Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson’s disease. pp. 345–371. 〈https://doi.org/10.1016/bs.pbr.2022.01.011〉.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献